Synthesis, characterization, cellular uptake, apoptosis, cytotoxicity, dna-binding, and antioxidant activity studies of ruthenium(II) complexes

Nucleosides, Nucleotides and Nucleic Acids

Volumn 31, Issue 8, 2012, Pages 575-591

  Xu, Li ^a   Zhong, Nan Jing ^a   Huang, Hong Liang ^a   Liang, Zhen Hua ^a   Li, Zheng Zheng ^a   Liu, Yun Jun ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

apoptosis; cellular uptake; cytotoxicity; DNA binding; Ruthenium complex

Indexed keywords

CISPLATIN; HYDROXYL RADICAL; RUTHENIUM COMPLEX; SINGLET OXYGEN;

ABSORPTION SPECTROSCOPY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CELL ASSAY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA CLEAVAGE; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; INTERCALATION COMPLEX; INTERNALIZATION; NONHUMAN; PHOTOACTIVATION; VISCOSITY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; COORDINATION COMPLEXES; DNA; DNA CLEAVAGE; HUMANS; OXIDATION-REDUCTION; RUTHENIUM; VISCOSITY;

EID: 84865791727     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2012.704110     Document Type: Article

References (45)

1. Zuber, G. Jr.; Quada, J.C.; Hecht, S.M. Sequence selective cleavage of a DNA octanucleotide by chlorinated bithiazoles and bleomycins. J. Am. Chem. Soc. 1998, 120, 9368-9369. (Pubitemid 28452714)
2. Li, V.S.; Choi, D.; Wang, Z.; Jimenez, L.S.; Tang, M.S.; Kohn, H. Role of the C-10 substituent in mitomycin C-1?DNA bonding. J. Am. Chem. Soc. 1996, 118, 2326-2331. (Pubitemid 26120916)
3. Zhang, H.; Liu, C.S.; Bu, X.H.; Yang, M. Synthesis, crystal structure, cytotoxic activity and DNA-binding properties of the copper (II) and zinc (II) complexes with 1-[3- (2-pyridyl)pyrazol-1- ylmethyl]naphthalene. J. Inorg. Biochem. 2005, 99, 1119-1125.
4. Mariappan, M.; Maiya, B.G. Effects of anthracene and pyrene units on the interactions of novel polypyridylruthenium (II) mixed-ligand complexes with DNA. Eur. J. Inorg. Chem. 2005, 11, 2164-2173. (Pubitemid 40831283)
5. Du, K.J.; Wang, J.Q.; Kou, J.F.; Li, G.Y.; Wang, L.L.; Chao, H.; Ji, L.N. Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium (II) polypyridyl complexes. Eur. J. Med. Chem. 2011, 46, 1056-1065.
6. Brodie, C.R.; Aldrich-Wright, J.R. Effects of anthracene and pyrene units on the interactions of novel polypyridylruthenium (II) mixed-ligand complexes with DNA. Eur. J. Inorg. Chem. 2007, 30, 4781-4793.
7. Wang, B.D.; Yang, Z.Y.; Wang, Q.; Cai, T.K.; Crewdson, P. Synthesis, characterization, cytotoxic activities, and DNA-binding properties of the La (III) complex with naringenin Schiff-base. Bioorg. Med. Chem. 2006, 14, 1880-1888. (Pubitemid 43199520)
8. Jiang, C.W. Dimeric 2,2-bipyridylruthenium (II) complexes containing 2,2-bis (1,2,4-triazin-3-yl)-4,4- bipyridine-like bridging ligands: syntheses, characterization and DNA binding. Eur. J. Inorg. Chem. 2004, 11, 2277-2282.
9. Zhou, J.; Wang, L.F.; Wang, J.Y.; Tang, N. Synthesis, characterization, antioxidative and antitumor activities of solid quercetin rare earth (III) complexes. J. Inorg. Biochem. 2001, 83, 41-48.
10. Rosenberg, B.; VanCamp, L.; Trosko, J.E.;Mansour, V.H. Platinum compounds: a new class of potent antitumor agents. Nature 1969, 222, 385-386.
11. Bratsos, I.; Jedner, S.; Gianferrara, T.; Alessio, E. Ruthenium anticancer compounds: challenges and expectations. Chimia 2007, 61, 692-697.
12. Meng, X.; Leyva, M.L.; Jenny, M.; Gross, I.; Benosman, S.; Harlepp, B.; Hébraud, P.; Boos, A.; Wlosik, P.; Bischoff, P.; Sirlin, C.; Pfeffer, M.; Loeffler, J.P.; Gaiddon, C. A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene chop. Cancer Res. 2009, 69, 5458-5466.
13. Tan, C.P.; Wu, S.H.; Lai, S.S.; Wang, M.X.; Chen, Y.; Zhou, L.J.; Zhu, Y.P.; Lian, W.; Peng, W.L.; Ji, L.N.; Xu, A.L. Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-norharman complexes. Dalton Trans. 2011, 40, 8611-8621.
14. Tan, L.F.; Shen, J.L.; Liu, J.; Zeng, L.L.; Jin, L.H.;Weng, C. Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru (II) mixed-ligand complexes. Dalton Trans. 2012, 41, 4575-4587.
15. Mulyana, Y.Y.; Collins, G.; Keene, R. Synthesis, nucleic acid binding and cytotoxicity of oligonuclear ruthenium complexes containing labile ligands. J. Incl. Phenom. Macrocycl. Chem. 2011, 71, 371-379.
16. Liu, Y.J.; Zeng, C.H.; Huang, H.L.; He, L.X.; Wu, F.H. Synthesis, DNA-binding, photocleavage, cytotoxicity and antioxidant activity of ruthenium (II) polypyridyl complexes. Eur. J. Med. Chem. 2010, 45, 564-571.
17. Liu, Y.J.; Zeng, C.H.; Liang, Z.H.; Yao, J.H.; Huang, H.L.; Wu, F.H. Synthesis of ruthenium (II) complexes and characterization of their cytotoxicity in vitro, apoptosis,DNA-binding and antioxidant activity. Eur. J. Med. Chem. 2010, 45, 3087-3095.
18. Liu, Y.J.; Li, Z.Z.; Liang, Z.H.; Huang, H.L. Cytotoxicity, apoptosis, cellular uptake, cell cycle arrest, photocleavage and antioxidant activity of 1,10-phenanthroline ruthenium (II) complexes. DNA Cell Biol. 2011, 30, 839-848.
19. Marmur, J. A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J. Mol. Biol. 1961, 3, 208-218.
20. Reichmann, M.E.; Rice, S.A.; Thomas, C.A.; Doty, P. A further examination of the molecular weight and size of deoxypentose nucleic acid. J. Am. Chem. Soc. 1954, 76, 3047-3053.
21. Sullivan, B.P.; Salmon, D.J.; Meyer, T.J. Mixed phosphine 2,2-bipyridine complexes of ruthenium. Inorg. Chem. 1978, 17, 3334-3341.
22. Xin, H.; Li, F.Y.; Guan, M.; Huang, C.H.; Sun, M.; Wang, K.Z.; Zhang, Y.A.; Jin, L.P. Carbazolefunctionalized europium complex and its high-efficiency organic electroluminescent properties. J. Appl. Phys. 2003, 94, 4729-4731.
23. Wolf, A.; Shimer, G.H. Jr.; Meehan, T. Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA. Biochemistry 1987, 26, 6392-6396. (Pubitemid 17155512)
24. Chaires, J.B.; Dattagupta, N.; Crothers, D.M. Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on the interaction of daunomycin with deoxyribonucleic acid. Biochemistry 1982, 21, 3933-3940. (Pubitemid 13237187)
25. Satyanarayana, S.; Dabrowiak, J.C.; Chaires, J.B. Tris (phenanthroline) ruthenium (II) enantiomer interactions with DNA: mode and specificity of binding. Biochemistry 1993, 32, 2573-2584. (Pubitemid 23090644)
26. Satyanaryana, S.; Dabrowial, J.C.; Chaires, J.B. Neither- nor-tris (phenanthroline) ruthenium (II) binds to DNA by classical intercalation. Biochemistry 1992, 31, 9319-9324.
27. Cohen, G.; Eisenberg, H. Viscosity and sedimentation study of sonicated DNA-proflavine complexes. Biopolymers 1969, 8, 45-55.
28. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63. (Pubitemid 14203433)
29. Spector, D.L.; Goldman, R.D.; Leinwand, L.A. Cells: A Laboratory Manual, Volume 1, Cold Spring Harbor Laboratory Press, New York, 1998.
30. Hickman, J.A. Apoptosis induced by anticancer drugs. Cancer Metast. Rev. 1992, 11, 121-139.
31. Liu, J.G.; Zhang, Q.L.; Shi, X.F.; Ji, L.N. Interaction of [Ru (dmp)2 (dppz)]2+ and [Ru (dmb)2 (dppz)]2+ with DNA: Effects of the ancillary ligands on the DNA-binding behaviors. Inorg. Chem. 2001, 40, 5045-5050.
32. Zeng, C.H.; Liu, Y.J.; Li, Z.Z.; Liang, Z.H.; Huang, H.L.; Wu, F.H. DNA-binding, antioxidant activity and in vitro cytotoxicity induced by ruthenium (II) complexes containing polypyridyl ligands. Transition Met. Chem. 2010, 35, 731-736.
33. Arockiasamy, D.L.; Radhika, S.; Parthasarathi, R.; Nair, B.N. Synthesis and DNA-binding studies of two ruthenium (II) complexes of an intercalating ligand. Eur. J. Med. Chem. 2009, 44, 2044-2051.
34. Grueso, E.; Lopez-Pérez, G.; Castellano, M.; Prado-Gotor, R. Thermodynamic and structural study of phenanthroline derivative ruthenium complex/DNA interactions: probing partial intercalation and binding properties. J. Inorg. Biochem. 2012, 106, 1-9.
35. Kelly, J.M.; McConnell, D.J.; OhUigin, C.; Tosssi, A.B.; Mesmaeker, A.K-D.; Masschelein, A.; Nasieski, J. Comparative study of Ru (bpz)3 2+ Ru (bipy)3 2+ and Ru (bpz)2Cl2 as photosensitizers of DNA cleavage and adduct formation. J. Chem. Soc. Chem. Commun. 1987, 24, 1821-1823.
36. Vicendo, P.; Mouysset, S.; Paillous, N. Comparative study of Ru (bpz)3 2+ Ru (bipy)3 2+ and Ru (bpz)2Cl2 as photosensitizers of DNA cleavage and adduct formation. Photochem. Photobiol. 1997, 65, 647-655.
37. Cheng, C.C.; Rokita, S.E.; Burrows, C.J. Nickel (III)-catalyzed DNA cleavage with air oxygen. Angew. Chem. Int. Ed. Engl. 1993, 32, 277-278.
38. Lesko, S.A.; Lorentzen, R.J.; Ts'o, P.O. Role of superoxide in deoxyribonucleic acid strand scission. Biochemistry 1980, 19, 3023-3028.
39. Nilsson, R.; Merkel, P.B.; Kearns, D.R. Unambiguous evidence for the participation of single oxygen (1) in photodynamic oxidation of amino acid. Photochem. Photobiol. 1972, 16, 117-124.
40. Patra, A.K.; Nethaji, M.; Chakravarty, A.R. Synthesis, crystal structure, DNA binding and photoinduced DNA cleavage activity of (S-methyl-L-cysteine) copper (II) complexes of heterocyclic bases. J. Inorg. Biochem. 2007, 101, 233-244. (Pubitemid 46074152)
41. Deshpande, M.S.; Kumbhar, A.A.; Kumbhar, A.S.; Kumbhakar, M.; Pal, H.; Sonawane, U.B.; Joshi, R.R. Ruthenium (II) complexes of bipyridine-glycoluril and their interactions with DNA. Bioconjugate Chem. 2009, 20, 447-459.
42. Gao, F.; Chao, H.; Ji, L.N. DNA binding, photocleavage, and topoisomerase inhibition of functionalized ruthenium (II)-polypyridine complexes. Chem. Biodivers. 2008, 5, 1962-1979.
43. Tsai, K.; Hsu, T.G.; Hsu, K.M.; Cheng, H.; Liu, T.Y.; Hsu, C.F.; Kong, C.W. Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise. Free Radical. Biol. Med. 2001, 31, 1465-1472. (Pubitemid 33145317)
44. Udilova, N.; Kozlov, A.V.; Bieberschulte, W.; Frei, K.; Ehrenberger, K.; Nohl, H. The antioxidant activity of caroverine. Biochem. Pharm. 2003, 65, 59-65. (Pubitemid 35447839)
45. Huang, H.L.; Liu, Y.J.; Zeng, C.H.; He, L.X.; Wu, F.H. In vitro cytotoxicity, apoptosis, DNA-binding, and antioxidant activity studies of ruthenium (II) complexes. DNA Cell Biol. 2010, 29, 261-270.